🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, physicians and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering substances of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, potentially leading to penalties, legal action or prison.

Platform Response and Material Elimination

Based on TikTok, the platform has removed problematic content and prohibited related keywords and search suggestions. The company said it was committed to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Operations

Investigations also found communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of slimming results, positive reviews and step-by-step guides for mixing or injecting at residence.

Within moments of entering one community, a vendor posted WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.

Product Details and Costs

Within these communities, messages display dark colored parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has already encountered patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly significant health risks”.